PTAB Wins For Bass May Not Move Needle On Drug Prices
Hedge fund manager Kyle Bass' controversial campaign of inter partes reviews targeting drug patents has resulted in three wins so far, although attorneys say it's not clear he's any closer to...To view the full article, register now.
Already a subscriber? Click here to view full article